A targeted drug-delivery system called TAMP aims to send chemotherapy near pancreatic tumors instead of through the entire ...
Researchers from the National University of Singapore (NUS) have discovered that cancer cells do not simply push through ...
Preliminary results from a preclinical study demonstrated statistically significant increase in MHC-I expression following ...
18hon MSN
Breast cancer cells with doubled genomes may dodge immunotherapy by turning off key immune signals
An epigenetic mechanism by which tumors manage to hide from the body's immune defenses has just been described by an ...
Stem cells found in the lining of the mouth could help make the most aggressive form of brain cancer easier to treat, ...
A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for ...
MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines—an advance that could lead to much ...
The first clinical trial to test the tumour-fighting power of a stem-cell-like class of long-lived immune cells suggests that ...
Medications are designed to treat diseased tissues while sparing healthy ones, often by attaching the drug to something that helps guide it directly to its target. But drugs also need time to work, ...
A new study by the Garvan Institute of Medical Research has uncovered a hidden mechanism explaining why breast cancer can ...
India's TDB is supporting Helix Cell Therapeutics to develop an affordable, dual-targeting CAR-T therapy for multiple myeloma, aiming to improve treatment outcomes via Indo-Singapore collaboration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results